|Articles|January 1, 2012
- BioPharm International-01-01-2012
- Volume 25
- Issue 1
BioPharm International, January 2012 Issue (PDF)
Therapeutic Vaccines
Advertisement
Articles in this issue
almost 14 years ago
Auditing by the Numbersalmost 14 years ago
Here's to a Year of Compromisealmost 14 years ago
USAID Moves Global Healthcare Initiatives Forwardalmost 14 years ago
Therapeutic Vaccine Outlookalmost 14 years ago
Budget Crunch, Political Battles Shape Policy Agenda for Yearalmost 14 years ago
A 25-Year Retrospective on Separations Technologyalmost 14 years ago
An Overview of Risk Assessment Strategies for Extractables and Leachablesalmost 14 years ago
Global Economic Woes Overshadow Biotech Industry Advances in 2011Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
